|
|
|
|
|
|
|
|
|
|
|
|
|
13.08.26 - 13:54
|
Here Are Thursday′s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: Futures are trading higher, as traders and investors breathed a big sigh of relief on Wednesday after the consumer price index data came in right on Wall Street expectations, with a 3.4% year-over-year print and a 0.01% month-over-month increase. Core CPI, which excludes the volatile food and energy costs, rose 2.5%. After ... Here Are Thursday's Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.08.26 - 17:48
|
Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant (24/7 Wall St.)
|
|
|
Abbott Laboratories (NYSE:ABT) currently trades at $105.70, while the Street's consensus price target sits at $118.42, implying roughly 12% of upside. Barclays analyst Matt Miksic carries the highest active target at $143, translating to about 35% in gains from here. Abbott is a diversified healthcare giant with a market cap near $182.9 billion, operating across ... Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
